No abstract available
Keywords:
Complete molecular remission; Minimal residual disease; Molecular relapse; Ph+ acute lymphoblastic leukemia; Tyrosine kinase inhibitors.
MeSH terms
-
Adolescent
-
Adult
-
Combined Modality Therapy
-
Dasatinib
-
Female
-
Humans
-
Male
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery*
-
Protein Kinase Inhibitors / therapeutic use*
-
Pyrimidines / therapeutic use*
-
Remission Induction
-
Stem Cell Transplantation / methods*
-
Thiazoles / therapeutic use*
-
Transplantation, Homologous
-
Young Adult
Substances
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Thiazoles
-
Dasatinib